Stroke risk factors beyond the CHA2DS2-VASc score: can we improve our identification of “high stroke risk” patients with atrial fibrillation?

FM Szymanski, GYH Lip, KJ Filipiak, AE Platek… - The American journal of …, 2015 - Elsevier
The prevention of stroke and other thromboembolic events plays a crucial role in the
management of patients with atrial fibrillation. Not all patients with atrial fibrillation are equal …

CHA2DS2-VASc Score is a Predictor of No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Intervention

G Ipek, T Onuk, MB Karatas, B Gungor, A Osken… - …, 2016 - journals.sagepub.com
Thrombosis and distal embolization play crucial role in the etiology of no-reflow. CHA2DS2-
VASc score is used to estimate the risk of thromboembolism in patients with atrial fibrillation …

Stroke risk scores as predictors of severe outcomes in atrial fibrillation: a comprehensive review

AC Ivănescu, CA Buzea, C Delcea… - American Journal of …, 2021 - journals.lww.com
Stroke Risk Scores as Predictors of Severe Outcomes in Atria... : American Journal of
Therapeutics Stroke Risk Scores as Predictors of Severe Outcomes in Atrial Fibrillation: A …

[HTML][HTML] Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention

Y Liu, Y Yao, X Tang, N Xu, L Jiang, Z Gao, J Chen… - Journal of …, 2020 - Elsevier
Background Inflammation plays a pivotal role in coronary artery disease (CAD). Few data
from large-size studies are available on the association of high-sensitivity C-reactive protein …

Correlating stroke risk with non-invasive cerebrovascular perfusion dynamics using a portable speckle contrast optical spectroscopy laser device

YX Huang, S Mahler, A Abedi, JM Tyszka… - Biomedical Optics …, 2024 - opg.optica.org
Stroke poses a significant global health threat, with millions affected annually, leading to
substantial morbidity and mortality. Current stroke risk assessment for the general …

[PDF][PDF] CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and …

H Taşolar, M Çetin, M Ballı… - Anatolian Journal of …, 2016 - jag.journalagent.com
Objective: We recently described the CHA2DS2-VASc-HS score as a novel predictor of
coronary artery disease (CAD) severity in stable CAD patients. We aimed to assess the …

CHA2DS2-VASc score and clinical outcomes of patients with acute coronary syndrome

Z Rozenbaum, A Elis, M Shuvy, D Vorobeichik… - European Journal of …, 2016 - Elsevier
Abstract Background The CHA2DS2-VASc score has been recommended for the
assessment of thromboembolic risk in patients with atrial fibrillation. Hypothesis The …

CHA2DS2-VASc Score Predicts In-Hospital and Long-Term Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Who Were Undergoing …

M Bozbay, H Uyarel, G Cicek, A Oz… - Clinical and Applied …, 2017 - journals.sagepub.com
CHA2DS2-VASc score includes similar risk factors for coronary artery disease. We
hypothesized that admission CHA2DS2-VASc score might be predictive of adverse clinical …

New CHA2DS2-VASc-HSF score predicts the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation …

QY Zhang, SM Ma, JY Sun - BMC Cardiovascular Disorders, 2020 - Springer
Background The no-reflow phenomenon (NRP) is a serious complication of primary
percutaneous coronary intervention (PPCI) and is an independent predictor of poor …

Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on …

D Capodanno, R Rossini, G Musumeci… - International journal of …, 2015 - Elsevier
Abstract Background The CHA 2 DS 2-VASc and HAS-BLED are well-validated stroke risk
prediction scores for atrial fibrillation (AF), but their role in risk stratification of major adverse …